Tumor localization and antitumor efficacy of novel sapphyrin compounds
Open Access
- 1 November 2006
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Therapeutics
- Vol. 5 (11), 2798-2805
- https://doi.org/10.1158/1535-7163.mct-06-0246
Abstract
Sapphyrins are pentapyrrolic metal-free expanded porphyrins with potential medical use as anticancer agents. The novel sapphyrin derivative, PCI-2050, functionalized with 2-[2-(2-methoxyethoxy)ethoxy]ethoxy groups to enhance solubility and a modified bipyrrole moiety was found to be more potent in inducing apoptosis than the previously described sapphyrin PCI-2000. Because some sapphyrins may localize to tumors, we took advantage of the intrinsic fluorescence of these compounds to develop a flow cytometry–based assay to track sapphyrin biodistribution in tumor-bearing mice. Ex vivo analysis of sapphyrin-injected animals revealed that PCI-2050 preferentially localized to tumor, whereas PCI-2000 distributed into normal tissues rather than tumor. PCI-2050 uptake in xenograft tumor cells and resultant tumor cell cytotoxicity was dose dependent. To investigate structure–activity relationships, we focused on PCI-2050 and three derivatives that differ by their alkyl substituents on the bipyrrole moiety: PCI-2051, PCI-2052, and PCI-2053. Treatment of Ramos cells in culture or treatment of Ramos xenograft-bearing animals with each of the sapphyrins followed by ex vivo growth of tumor cells revealed the same pattern of cytotoxicity: PCI-2050 > PCI-2052 > PCI-2051 > PCI-2053. Thus, subtle changes in the alkyl substituents on the bipyrrole moiety result in significant changes in antitumor activity. PCI-2050 displayed significant antitumor efficacy in both Ramos and RKO xenograft models without hematologic, hepatic, or renal abnormalities as assessed by complete blood counts and serum chemistries. On the basis of these findings, it is concluded that the sapphyrin PCI-2050 warrants further evaluation as a potential anticancer agent due to its intrinsic proapoptotic activity and tumor localization ability. [Mol Cancer Ther 2006;5(11):2798–805]Keywords
This publication has 15 references indexed in Scilit:
- Sapphyrins induce apoptosis in hematopoietic tumor–derived cell lines and show in vivo antitumor activityMolecular Cancer Therapeutics, 2005
- ERK and p38 MAPK-Activated Protein Kinases: a Family of Protein Kinases with Diverse Biological FunctionsMicrobiology and Molecular Biology Reviews, 2004
- Biolocalisation and photochemical properties of two novel macrocyclic photosensitisers: a spectroscopic studyJournal of Photochemistry and Photobiology B: Biology, 2004
- Mitogen-activated protein kinases in apoptosis regulationOncogene, 2004
- Water soluble sapphyrins: potential fluorescent phosphate anion sensorsOrganic & Biomolecular Chemistry, 2003
- Synthesis of sapphyrins via a ‘3+1+1’ procedureTetrahedron Letters, 2001
- Expanded porphyrins. Synthetic materials with potential medical utilityPublished by Walter de Gruyter GmbH ,1999
- SPECTROSCOPY AND PHOTOSENSITIZATION OF SAPPHYRINS IN SOLUTIONS AND BIOLOGICAL MEMBRANESPhotochemistry and Photobiology, 1994
- Porphyrins as contrast mediaMagnetic Resonance in Medicine, 1991
- In vitro PHOTODYNAMIC INACTIVATION OF Herpes simplex VIRUS WITH SAPPHYRINS: 22 π‐ELECTRON PORPHYRIN‐LIKE MACROCYCLESPhotochemistry and Photobiology, 1991